Form 4: Elevance Health Executive Felicia Norwood Reports Stock Transactions

Felicia Norwood, EVP & President of Government Health Benefits at Elevance Health, reports the exercise of stock options and subsequent sale of shares.

Summary

• Felicia Norwood, an executive at Elevance Health, filed a Form 4 detailing changes in her beneficial ownership of the company's stock.
• On April 23, 2024, Norwood exercised stock options to acquire 5,473 shares at a price of $238.27 per share and sold 14,011 shares at a weighted average price of $533.73.
• She also sold 100 shares at $534.74 on the same day.
• On April 24, 2024, she exercised options for 2,043 shares at $238.27 per share and sold 2,765 shares at a weighted average price of $532.14.
• Additionally, she sold 3,434 shares at a weighted average price of $532.68 on April 24, 2024.
• Following these transactions, Norwood directly owns 27,304 shares of Elevance Health common stock.

Sentiment

Score: 5

Explanation: This is a routine disclosure of stock transactions by a company executive. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Comparison to Industry Standards

• It's common for executives at publicly traded companies like Elevance Health to receive stock options as part of their compensation packages.
• The exercise of these options and subsequent sale of shares is a normal financial planning activity.
• Similar transactions are regularly reported by executives at companies such as UnitedHealth Group (UNH) and CVS Health (CVS).

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.

Key Dates